Idun Genomics IVS: Financial statements 2018
CVR: 38003429
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Idun Genomics IVS (CVR 38003429) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 0 and a net result of DKK 1,406. Equity in the 2018 report amounted to DKK 1,408. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 1,406
- Equity
- DKK 1,408
- Total Assets
- DKK 1,408
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of December 6, 2018, Lasse Westergaard Folkersen has left the board of directors of Idun Genomics IVS.
Idun Genomics IVS has published its interim report for the period September 12, 2016 to December 31, 2017.
About Idun Genomics IVS
Idun Genomics IVS was a Danish company of the type Iværksætterselskab based in Allerød, founded in 2016. The company has been dissolved on 7 January 2021. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2018, the company reported a gross profit of DKK 0 and a net result of DKK 1,406. Equity in the 2018 report amounted to DKK 1,408.